Trial Profile
A randomized controlled patient blinded trial of Actiq in combination with midazolam as premedication for bone marrow biopsy in patients with hematologic malignancies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Midazolam (Primary) ; Lidocaine
- Indications Pain
- Focus Therapeutic Use
- 21 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association
- 25 Jun 2017 Primary endpoint (Efficacy) has been met, according to the abstract presented at the 22nd Congress of the European Haematology Association..